| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.4 | 3e-17 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-07 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.17 | 0.002 |